Point of Care Diagnostics Market

Point of Care Equipment Market was valued at USD 24,800 Million in 2019 and projected to expand at 10.3% during the forecast period.

Point of Care (POC) Diagnostics is performed near or at the site where the patient initially encounters the healthcare system and permits the medical staff and physicians to precisely achieve real-time, lab-quality results within some minutes rather than hours. It streamlines the diagnostics process and enables the staff to make rapid treatment decisions when monitoring the response of the treatment. The point of care diagnostics decreases the dependence on presumptive and hence simplify antibiotic stewardship.

To have an edge over the competition by knowing the market dynamics and current trends of “Point of Care (POC) Diagnostics Market”, request for Sample Report here

Major Point of Care Diagnostics Market Drivers

The major factors propelling the growth of the global point of care (POC) diagnostics market include the increase in the number of patients having infectious diseases and chronic conditions across various countries, which surged the demand for point of care diagnostics in the market. Moreover, a rise in support of the government to encourage the adoption of point of care diagnostics and increasing awareness related to the advantages associated with such diagnostics among the developing markets are some other factors which are bolstering the growth of the global point of care diagnostics market (POC) during the forecast period. Various technological advancements in the point of care diagnostics devices and growth in the R&D investments by the manufacturers to offer cost-effective tests to the consumers are further fuelling the growth of the market worldwide. The factors that are responsible for hindering the growth of the global point of care (POC) diagnostics market include the high cost of such devices and lack of knowledge related to the use of point of care diagnostics devices among the professionals.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Based on the product, the glucose monitoring products segment is projected to increase at a higher CAGR in the global point of care (POC) diagnostics market during the forecast period owing to the increasing demand for this type of products in the market as a result of the rising number of cases of diabetes across various countries and rapid growth in the aging population across the world. In addition to this, various technological advancements in glucose monitoring products is also a significant factor propelling the growth of the market in this segment.

Based on the platform, the lateral flow assays segment is anticipated to grow at a higher CAGR over the forecast period in the global point of care (POC) diagnostics market due to the rising adoption of lateral flow assays for point of care testing driven by its ability to offer analytical information cost-effectively and quickly. Moreover, the growing inclination towards lateral flow assays in order to avoid lengthy, conventional laboratory procedures is also a major factor that is driving the growth of the market in this segment.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Regional – Segment Analysis

Based on the region, the North America region is expected to increase a higher rate during the forecast period in the global point of care (POC) diagnostics market due to the increasing incidences of infectious diseases among the population and rising number of lifestyle diseases, which has surged the demand for point of care diagnostics in the market. In addition to this, the increasing demand for technologically advanced point of care diagnostic devices across the region is also a major factor that is driving the growth of the market.

Top Market Players

Various notable players operating in the market include BD, Abbott, Danaher, Chembio Diagnostics, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., EKF Diagnostics, Siemens Healthcare Private Limited, Trinity Biotech, and Quidel Corporation, among others. 

Key Developments:

• • In 2020, BD launched a portable, rapid, point-of-care SARS-CoV-2 diagnostic test to be used with the company’s Veritor Plus system to identify SARS-CoV-2. This assay has the ability to provide results in 15 minutes and is a highly portable instrument.
  • In 2019, Chembio Diagnostics, Inc. collaborated with Shire Human Genetic Therapies, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited. The companies planned to develop a POC diagnostic test to identify an undisclosed biomarker.

Segments covered in the Report:

The global point of care (POC) diagnostics market has been segmented on the basis of platform, mode of purchase, product, end user, and regions. Based on the platform, the market is segmented into dipsticks, lateral flow assays, molecular diagnostics, microfluidics, and immunoassays. Based on the mode of purchase, the market is segmented into OTC products and prescription-based products. Based on product, the market is segmented into cardiometabolic monitoring products, glucose monitoring products, infectious disease testing products, coagulation monitoring products, tumor/cancer marker testing products, pregnancy & fertility testing products, cholesterol testing products, urinalysis testing products, drugs-of-abuse testing products, hematology testing products, fecal occult testing products, and other POC products. The cardiometabolic monitoring products segment is further categorized into blood gas/electrolyte testing products, cardiac marker testing products, and Hba1c testing products. The glucose monitoring products segment is further categorized into meters, strips, and lancets & lancing devices. The infectious disease testing products segment is further categorized into HIV testing products, influenza testing products, sexually transmitted disease testing products, hepatitis C testing products, respiratory infection testing products, healthcare-associated infection testing products, tropical disease testing products, and other infectious disease testing products. The coagulation monitoring products segment is further categorized into Act/Aptt testing products and Pt/Inr testing products. The pregnancy & fertility testing products segment is further categorized into fertility testing products and pregnancy testing products. Based on the end user, the market is segmented into hospitals/critical care centers, professional diagnostic centers, research laboratories, home care settings, and other end users. 

For detailed scope of the “Point of Care (POC) Diagnostics Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is the global point of care (POC) diagnostics market growing? What will be the growth trend in the future?
  • What are the key drivers and restraints in the point of care (POC) diagnostics market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global point of care (POC) diagnostics market?
  • Which product generated maximum revenues in 2019 and identify the most promising product during the forecast period?
  • What are the various end users of the global point of care (POC) diagnostics market and how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Market Segmentation

Global Point of Care (POC) Diagnostics Market by Platform

• • Dipsticks
  • Lateral Flow Assays
  • Molecular Diagnostics
  • Microfluidics
  • Immunoassays

Global Point of Care (POC) Diagnostics Market by Mode of Purchase

• • OTC Products
  • Prescription-Based Products

Global Point of Care (POC) Diagnostics Market by Product

• • Cardiometabolic Monitoring Products
    • Blood Gas/Electrolyte Testing Products
    • Cardiac Marker Testing Products
    • Hba1c Testing Products
  • Glucose Monitoring Products
    • Meters
    • Strips
    • Lancets & Lancing Devices
  • Infectious Disease Testing Products
    • HIV Testing Products
    • Influenza Testing Products
    • Sexually Transmitted Disease Testing Products
    • Hepatitis C Testing Products
    • Respiratory Infection Testing Products
    • Healthcare-Associated Infection Testing Products
    • Tropical Disease Testing Products
    • Other Infectious Disease Testing Products
  • Coagulation Monitoring Products
    • Act/Aptt Testing Products
    • Pt/Inr Testing Products
  • Tumor/Cancer Marker Testing Products
  • Pregnancy & Fertility Testing Products
    • Fertility Testing Products
    • Pregnancy Testing Products
  • Cholesterol Testing Products
  • Urinalysis Testing Products
  • Drugs-of-Abuse Testing Products
  • Hematology Testing Products
  • Fecal Occult Testing Products
  • Other POC Products

Global Point of Care (POC) Diagnostics Market by End User

• • Hospitals/Critical Care Centers
  • Professional Diagnostic Centers
  • Research Laboratories
  • Home Care Settings
  • Other End Users

Global Point of Care (POC) Diagnostics Market by Region

• • North America Point of Care (POC) Diagnostics Market (Option 1: As a part of the free 25% customization)

    • North America Point of Care (POC) Diagnostics Market by Platform
    • North America Point of Care (POC) Diagnostics Market by Mode of Purchase
    • North America Point of Care (POC) Diagnostics Market by Product
    • North America Point of Care (POC) Diagnostics Market by End User
    • US Point of Care (POC) Diagnostics Market All-Up
    • Canada Point of Care (POC) Diagnostics Market All-Up

  • Europe Point of Care (POC) Diagnostics Market (Option 2: As a part of the free 25% customization)

    • Europe Point of Care (POC) Diagnostics Market by Platform
    • Europe Point of Care (POC) Diagnostics Market by Mode of Purchase
    • Europe Point of Care (POC) Diagnostics Market by Product
    • Europe Point of Care (POC) Diagnostics Market by End User
    • UK Point of Care (POC) Diagnostics Market All-Up
    • Germany Point of Care (POC) Diagnostics Market All-Up
    • France Point of Care (POC) Diagnostics Market All-Up
    • Spain Point of Care (POC) Diagnostics Market All-Up
    • Rest of Europe Point of Care (POC) Diagnostics Market All-Up

  • Asia-Pacific Point of Care (POC) Diagnostics Market (Option 3: As a part of the free 25% customization)

    • Asia-Pacific Point of Care (POC) Diagnostics Market by Platform
    • Asia-Pacific Point of Care (POC) Diagnostics Market by Mode of Purchase
    • Asia-Pacific Point of Care (POC) Diagnostics Market by Product
    • Asia-Pacific Point of Care (POC) Diagnostics Market by End User
    • China Point of Care (POC) Diagnostics Market All-Up
    • India Point of Care (POC) Diagnostics Market All-Up
    • Japan Point of Care (POC) Diagnostics Market All-Up
    • Rest of APAC Point of Care (POC) Diagnostics Market All-Up

  • RoW Point of Care (POC) Diagnostics Market (Option 4: As a part of the free 25% customization)

    • RoW Point of Care (POC) Diagnostics Market by Platform
    • RoW Point of Care (POC) Diagnostics Market by Mode of Purchase
    • RoW Point of Care (POC) Diagnostics Market by Product
    • RoW Point of Care (POC) Diagnostics Market by End User
    • Brazil Point of Care (POC) Diagnostics Market All-Up
    • South Africa Point of Care (POC) Diagnostics Market All-Up
    • Saudi Arabia Point of Care (POC) Diagnostics Market All-Up
    • UAE Point of Care (POC) Diagnostics Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Point of Care (POC) Diagnostics Market All-Up

Major Players Operating in the Point of Care (POC) Diagnostics Market (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • BD
  • Abbott
  • Danaher
  • Chembio Diagnostics, Inc.
  • Hoffmann-La Roche Ltd
  • Johnson & Johnson Services, Inc.
  • EKF Diagnostics
  • Siemens Healthcare Private Limited
  • Trinity Biotech
  • Quidel Corporation